NORTHWEST BIOTHERAPEUTICS INC Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for the quarter ending 2020-12-31 was $7.63M, a 166.47% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for the quarter ending 2020-09-30 was $3.91M, a 223.06% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for the quarter ending 2020-06-30 was $2.90M.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for the quarter ending 2020-03-31 was $2.04M.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for fiscal 2024 was $14.02M.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for fiscal 2022 was $9.69M, a 138.06% increase from fiscal 2021.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for fiscal 2021 was $4.07M, a 75.32% decline from fiscal 2020.
- NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, other for fiscal 2020 was $16.49M, a 304.89% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2024-12-31 | $14.02M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $9.69M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $4.07M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $16.49M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.91M 10-Q · filed 2021-11-15 | $11.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.90M 10-Q · filed 2021-08-16 | $9.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.04M 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.07M 10-K · filed 2022-03-01 |
| 2019-09-30 | $1.21M 10-Q · filed 2021-01-15 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $700.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2018-06-30 | $700.00K 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | $2.54M 10-K · filed 2019-04-02 |
| 2017-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $8.83M derived: sum of 4 quarters · filed 2018-04-17 |
| 2017-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | $11.38M derived: sum of 4 quarters · filed 2018-04-17 |
| 2017-03-31 | $1.21M 10-Q · filed 2017-05-15 | $11.19M derived: sum of 4 quarters · filed 2018-04-17 |
| 2016-12-31 | $6.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $19.99M 10-K · filed 2018-04-17 |
| 2016-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | |
| 2016-03-31 | $10.00M 10-Q · filed 2016-05-11 | |
| 2014-12-31 | $2.00K 10-K · filed 2016-03-16 | |
| 2014-09-30 | $2.00K 10-Q · filed 2014-11-19 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-11-19 | |
| 2011-12-31 | $797.00K 10-K · filed 2014-04-01 | |
| 2010-12-31 | $2.63M 10-K · filed 2014-04-01 |